rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Tilray Brands, Inc.

TLRY · Nasdaq

Health CarePharmaceuticalsNot moving yetCannabis

TLRY stood above a rising 150-day average in 7 of the last 52 weekly readings, and has been out of that trend for the last 43 weeks. It is 41.0% below that average now. Pharmaceuticals: 34% of its 74 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 43
Industry in uptrend
34% -5 in 4 wk
Insider buys, 12 months
$138K
Insider sales, 12 months
$466K
Officials’ trades on record
13
Institutions holding
226 (+25)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 7 of 52 weeks.

22 Apr – 21 Oct
26%35%45%Apr 26Jun 26Jul 26Sep 26Oct 26

Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$444K$0$117KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

13 disclosed lines: House 13, Senate 0, executive 0; 2 people.

WhoDidAmountTraded
Brian J. Mast House: U.S. House ClerkFL18sold$1k–$15k18 Apr 2022filed 9 May 2022
Brian J. Mast House: U.S. House ClerkFL18exchanged$1k–$15k3 May 2021filed 5 Oct 2022
John A. Yarmuth House: U.S. House ClerkKY03bought$1k–$15k12 Feb 2021filed 19 Feb 2021
Brian J. Mast House: U.S. House ClerkFL18sold$50k–$100k10 Feb 2021filed 12 Aug 2022
Brian J. Mast House: U.S. House ClerkFL18sold$50k–$100k10 Feb 2021filed 17 Mar 2021
Brian J. Mast House: U.S. House ClerkFL18sold$15k–$50k9 Feb 2021filed 12 Aug 2022
Brian J. Mast House: U.S. House ClerkFL18sold$15k–$50k9 Feb 2021filed 12 Aug 2022
Brian J. Mast House: U.S. House ClerkFL18sold$15k–$50k9 Feb 2021filed 17 Mar 2021
Brian J. Mast House: U.S. House ClerkFL18sold$15k–$50k9 Feb 2021filed 17 Mar 2021
Brian J. Mast House: U.S. House ClerkFL18bought$15k–$50k6 Nov 2020filed 1 Dec 2020
John A. Yarmuth House: U.S. House ClerkKY03bought$1k–$15k5 Nov 2020filed 15 Nov 2020
Brian J. Mast House: U.S. House ClerkFL18sold$15k–$50k4 Feb 2019filed 12 Mar 2019

Insiders

Buy orders, 12 months3
Sale orders, 12 months1
Buyers · sellers3 · 1
WhoDidSharesTraded
Mitchell GendelGlobal General Counselbought2,500at $4.436 Aug 2026filed 7 Aug 2026
Carl A. MertonChief Financial Officerbought10,000at $4.624 Aug 2026filed 4 Aug 2026
Denise M. FaltischekChief Strategy Officerbought2,500at $4.783 Aug 2026filed 4 Aug 2026
David G. HopkinsonDirectorsold33,556at $6.9421 Apr 2026filed 22 Apr 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders226+25 on the quarter
New · exited50 · 24
Reported value$61.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Tidal Investments LLCreduced · filed 13 Aug 20262,498,656$11.2M-65,033−2.5%
SUSQUEHANNA INTERNATIONAL GROUP, LLPadded · filed 14 Aug 20261,021,777$4.6M+479,545+88.4%
MORGAN STANLEYadded · filed 13 Aug 2026995,145$4.5M+354,120+55.2%
CITADEL ADVISORS LLCadded · filed 14 Aug 2026868,147$3.9M+854,239+6142.1%
Point72 Asset Management, L.P.new · filed 14 Aug 2026648,506$2.9M+648,506
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.added · filed 14 Aug 2026646,762$2.9M+159,942+32.9%
AQR CAPITAL MANAGEMENT LLCadded · filed 14 Aug 2026512,599$2.3M+65,011+14.5%
BlackRock, Inc.added · filed 7 Aug 2026461,656$2.1M+38,758+9.2%
UBS Group AGreduced · filed 13 Aug 2026454,184$2.0M-198,817−30.4%
LAZARD ASSET MANAGEMENT LLCnew · filed 14 Aug 2026394,715$1.8M+394,715
31 Dec 2024 – 30 Jun 2026
9114218Dec 24Sep 25Dec 25Mar 26Jun 26

News

Everyone who traded it

Carl A. Merton Company insiderChief Financial Officer · last 26 Aug 20264 · 1
Denise M. Faltischek Company insiderChief Strategy Officer · last 26 Aug 20262 · 0
Irwin D. Simon Company insiderPresident and CEO · last 26 Aug 20262 · 0
Mitchell Gendel Company insiderGlobal General Counsel · last 26 Aug 20264 · 0
David G. Hopkinson Company insiderDirector · last 30 Jul 20260 · 1
Johann Michael Herhalt Company insiderDirector · last 30 Jul 20260 · 0
Thomas P. Looney Company insiderDirector · last 30 Jul 20260 · 0
David F. Clanachan Company insiderDirector · last 29 Jul 20260 · 0
Renah Persofsky Company insiderDirector · last 29 Jul 20260 · 0
Steven Michael Cohen Company insiderDirector · last 29 Jul 20260 · 0
Jodi L. Butts Company insiderDirector · last 30 Jul 20240 · 0
Brendan Kennedy Company insiderDirector · last 7 Nov 20221 · 33

Same industry

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2026 · to 31 May 202628.4%
Operating profit marginFY 2026 · to 31 May 2026-6.9%
Return on capital employedFY 2026 · to 31 May 2026-3.2%
Debt to equityFY 2026 · to 31 May 20260.01×
Interest coverFY 2026 · to 31 May 2026-2.11×
Research spendFY 2026 · to 31 May 20260.0%
Share count trendFY 2026 · to 24 Jul 20263.4%
Cash and equivalentsFY 2026 · to 31 May 2026$226.0M

Analyst forecasts

No analyst forecasts yet.